Beximco Pharmaceuticals (LSE:BXP) Total Assets : £469.8 Mil (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Beximco Pharmaceuticals Total Assets?

Beximco Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 was £469.8 Mil.

During the past 12 months, Beximco Pharmaceuticals's average Total Assets Growth Rate was 1.20% per year. During the past 3 years, the average Total Assets Growth Rate was 11.20% per year. During the past 5 years, the average Total Assets Growth Rate was 9.70% per year.

During the past 13 years, Beximco Pharmaceuticals's highest 3-Year average Total Assets Growth Rate was 17.80%. The lowest was 6.20%. And the median was 11.30%.

Total Assets is connected with ROA %. Beximco Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 was 7.75%. Total Assets is also linked to Revenue through Asset Turnover. Beximco Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 was 0.16.

Beximco Pharmaceuticals Total Assets Historical Data

The historical data trend for Beximco Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beximco Pharmaceuticals Total Assets Chart

Beximco Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Total Assets

Get a 7-Day Free Trial

329.27

335.33

349.56

442.57

462.70

Beximco Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															463.76	460.63	462.70	472.54	469.84

Beximco Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Beximco Pharmaceuticals's Total Assets for the fiscal year that ended in Jun. 2023 is calculated as

Total Assets	=	Total Equity (A: Jun. 2023 )	+	Total Liabilities (A: Jun. 2023 )
	=	318.605	+	144.097
	=	462.7

Beximco Pharmaceuticals's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	337.278	+	132.559
	=	469.8

Beximco Pharmaceuticals (LSE:BXP) Total Assets Explanation

Total Assets is connected with ROA %.

Beximco Pharmaceuticals's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	36.516	/	( (472.537	+	469.838)	/ 2 )
	=	36.516	/	471.1875
	=	7.75 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Beximco Pharmaceuticals's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	73.512	/	( (472.537	+	469.838)	/ 2 )
=	73.512	/	471.1875
=	0.16

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Beximco Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of Beximco Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Beximco Pharmaceuticals (LSE:BXP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beximco Pharmaceuticals Ltd (LSE:BXP) » Definitions » Total Assets

Traded in Other Exchanges

R2WA:Germany BXPHARMA:Bangladesh

Address

19 Dhanmondi, Road No. 7, Dhaka, BGD, 1205

Website

https://www.beximcopharma.com

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.